2019-nCoV Nucleocapsid protein (N-His) (STJP000025) STJP000025-100|產品目錄|代理商|上海91麻豆福利视频网生物科技有限公司

所在位置: 首頁> 產品目錄> S類> ST john's laboratory>

查看大圖

產品名稱：2019-nCoV Nucleocapsid protein (N-His) (STJP000025)
產品型號：STJP000025-100
產品廠商：ST john's laboratory
產品文檔：

你添加了1件商品查看購物車

簡單介紹：

2019-nCoV Nucleocapsid protein (N-His) (STJP000025)

詳情介紹：

Host:	E. coli
Note:	STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description:	2019-nCoV Nucleocapsid-N-His protein was developed from e. coli and has a target region of N-His. For use in research applications.

Formulation:	Supplied as a 0.22 Mu m filtered solution in 20mM TRIS, 500mM NaCl, 0.1mM EDTA, 10% Glycerol, pH8.0. Contact us for customized product form or formulation.
Immunoreactivity:	Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 Nucleocapsid at 2 Mu g/mL (100 Mu L/well) can bind Anti-Nucleocapsid antibody with a linear range of 0.12-1.64 ng/mL.2. Measured by its binding ability in a fun

Immunogen Region:	Met1-Ala419
Immunogen:	Recombinant SARS-CoV-2 (2019-nCoV) Nucleocapsid Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Ala419) of SARS-COV-2 (2019-nCoV) Nucleocapsid (Accession #QHD43423.2) fused with an 6×His tag at th

Background

Recombinant SARS-CoV-2 (2019-nCoV) Nucleocapsid Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Ala419) of SARS-COV-2 (2019-nCoV) Nucleocapsid (Accession #QHD43423.2) fused with an 6×His tag at the N-terminus.

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance

姓名：

電話：

您的需求：

產品名稱：2019-nCoV Nucleocapsid protein (N-His) (STJP000025)